ZyVersa Therapeutics, Inc. ZVSA
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 197.35% | -80.72% | 632.32% | -95.53% | 5.26% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 89.81% | -22.33% | -21.26% | -24.08% | 169.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -91.44% | 72.51% | -- | -- |
| Total Current Assets | 113.34% | -65.05% | 81.30% | -73.98% | 22.99% |
|
|
|||||
| Total Current Assets | 113.34% | -65.05% | 81.30% | -73.98% | 22.99% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -89.93% | 95.38% | -3.56% |
| Total Assets | 113.34% | -66.56% | -94.70% | -6.41% | 1.87% |
|
|
|||||
| Total Accounts Payable | 1.11% | 3.25% | 0.32% | 1.77% | 2.86% |
| Total Accrued Expenses | 26.06% | -11.90% | -0.60% | 21.60% | 26.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 242.02% | -7.86% | 858.90% | 0.00% | 0.00% |
| Total Other Current Liabilities | 242.02% | -7.86% | 858.90% | 0.00% | 0.00% |
| Total Current Liabilities | 16.74% | -0.24% | 0.60% | 5.72% | 6.88% |
|
|
|||||
| Total Current Liabilities | 16.74% | -0.24% | 0.60% | 5.72% | 6.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00% | 0.00% |
| Total Liabilities | 16.74% | -0.24% | -5.73% | 5.34% | 6.39% |
|
|
|||||
| Common Stock & APIC | 0.04% | 0.01% | 1.61% | 0.15% | 1.54% |
| Retained Earnings | -1.30% | -0.50% | -16.91% | -1.92% | -2.00% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -14.03% | -5.64% | -292.23% | -24.97% | -4.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.03% | -5.64% | -292.23% | -24.97% | -4.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.03% | -5.64% | -292.23% | -24.98% | -4.53% |
|
|
|||||